Impact of a clinical decision support system in an electronic health record to enhance detection of α1-antitrypsin deficiency

Chest

Volumn 140, Issue 1, 2011, Pages 198-204

  Jain, Anil ^a   McCarthy, Kevin ^a   Xu, Meng ^a   Stoller, James K ^a,b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

AGE; AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; ELECTRONIC MEDICAL RECORD; GENOTYPE; HISTIOCYTOSIS X; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOIDOSIS; SMOKING; UNITED STATES;

EID: 79960383877     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-1658     Document Type: Article

References (20)

1. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818-900.
2. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365(9478):2225-2236.
3. Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest. 2005;128(4):1989-1994.
4. Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. Chest. 2005;128(3): 1179-1186.
5. Aboussouan LS, Stoller JK. Detection of alpha-1 antitrypsin deficiency:A review. Respir Med. 2009;103(3):335-341.
6. Rahaghi F, Ortega I, Rahaghi N, et al. Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test(PFT) results. J of Chronic Obstructive Pulmonary Disease. 2009;6(1):26-30.
7. The Global Initiative for Chronic Obstructive Lung Disease. GOLD Web site. www.goldcopd.com. Accessed September 13, 2010.
8. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to succ ess. BMJ. 2005;330(7494):765-768. (Pubitemid 40522338)
9. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest. 1986;89(3):370-373. (Pubitemid 16126301)
10. Brantly ML, Mishra VS, Viranovskaya N, et al. Statewide targeted screening and detection of AAT deficiency. Am J Respir Crit Care Med. 2003;167:A222.
11. Bals R, Koczulla R, Kotke V, Andress J, Blackert K, Vogelmeier C. Identification of individuals with alpha-1- antitrypsin deficiency by a targeted screening program. Respir Med. 2007;101(8):1708-1714. (Pubitemid 46947877)
12. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293(10):1261-1263.
13. Bell LM, Grundmeier R, Localio R, et al. Electronic health record-based decision support to improve asthma care: a cluster-randomized trial. Pediatrics. 2010;125(4):e770-e777.
14. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352(10):969-977.
15. Love TE, Cebul RD, Einstadter D, et al; DIG-IT Investigators. Electronic medical record-assisted design of a cluster-randomized trial to improve diabetes care and outcomes. J Gen Intern Med. 2008;23(4):383-391. (Pubitemid 351464869)
16. Berner ES. Clinical Decision Support Systems: State of the Art. Rockville, MD: US Agency for Healthcare Research and Quality. 2009. AHRQ publication 09-0069-EF.
17. Shah NR, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc. 2006;13(1):5-11. (Pubitemid 41828329)
18. Minai OA, Stoller JK. Therapy for alpha1-antitrypsin deficiency: pharmacology and clinical recommendations. BioDrugs. 2000;13(2):135-147. (Pubitemid 30146440)
19. Juvelekian GS, Stoller JK. Augmentation therapy for alpha(1)- antitrypsin deficiency. Drugs. 2004;64(16):1743-1756. (Pubitemid 39215186)
20. Stoller JK, Smith P, Yang P, Spray J. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleve Clin J Med. 1994;61(6):461-467.